164 results
Page 3 of 9
8-K
EX-99.1
zsvf0ls
5 Aug 14
Discovery Labs Reports Second Quarter 2014 Financial Results
12:00am
424B5
b9g738ho2s
31 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
t6g4bo3sj6iv6dcjn39
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
66vyz74
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
l9iu4so
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
424B5
g7dvb0z8r6w l2n2
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
h2m6408lyn3
13 Mar 13
Discovery Labs Reports Fourth Quarter 2012 Financial Results
12:00am
424B5
w3h n7lwf0ir
13 Feb 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
jyd14m
4 Jan 13
Discovery Labs Announces Changes to Board of Directors and Appoints a New Chief Executive Officer
12:00am